From: The burden of metastatic disease of the femur on the Medicare system
Year | Men <65 | Women <65 | <65 group | Men 65+ | Women 65+ | 65+ group | Total |
---|---|---|---|---|---|---|---|
2005 | $721,491 | $995,625 | $1,717,115 | $6,864,726 | $8,274,647 | $15,139,373 | $16,856,488 |
2006 | $973,424 | $1,231,249 | $2,204,673 | $6,811,380 | $9,572,709 | $16,384,089 | $18,588,762 |
2007 | $804,462 | $1,245,873 | $2,050,335 | $7,364,483 | $9,348,865 | $16,713,348 | $18,763,683 |
2008 | $992,739 | $1,466,225 | $2,458,964 | $7,257,886 | $8,118,277 | $15,376,163 | $17,835,127 |
2009 | $1,067,505 | $1,741,063 | $2,808,569 | $7,119,188 | $9,660,526 | $16,779,715 | $19,588,283 |
2010 | $777,511 | $1,717,583 | $2,495,094 | $7,194,923 | $8,308,407 | $15,503,330 | $17,998,424 |
2011 | $989,193 | $1,475,928 | $2,465,122 | $6,372,876 | $8,091,785 | $14,464,661 | $16,929,783 |
2012 | $1,070,240 | $2,013,565 | $3,083,805 | $8,045,193 | $9,116,958 | $17,162,151 | $20,245,957 |
r2 | 0.29 | 0.79 | 0.73 | 0.11 | 0.02 | 0.005 | 0.13, |
p value | 0.17 | 0.003 | 0.007 | 0.43 | 0.75 | 0.87 | 0.38, |
Co (LCL; UCL) | 29,929 (−16,960; 76,817) | 119,551 (57,730; 181,293) | 149,440 (59,667; 239,213) | 64,564 (−123,165; 252,293) | −36,757 (−311,001; 237,487) | 27,807 (−358,709; 414,323) | 177,247 (−276,695; 631,190) |